BioRegenx, Inc.
BRGX
$0.01
$0.0041.11%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -285.45% | -173.53% | -209.20% | -540.39% | -182.47% |
| Total Depreciation and Amortization | -62.83% | 11.77% | 243.40% | 46,133.33% | -- |
| Total Amortization of Deferred Charges | 24.55% | -6.45% | 239.29% | -- | 466.10% |
| Total Other Non-Cash Items | 607.35% | 249.34% | 269.94% | 696.69% | 13.06% |
| Change in Net Operating Assets | 117.66% | 366.34% | 818.22% | 225.85% | -76.18% |
| Cash from Operations | 92.46% | 99.79% | 85.78% | 78.60% | -151.35% |
| Capital Expenditure | 96.83% | 100.00% | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -100.00% | -100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 76.60% | 76.60% | 101.34% | 100.00% | -- |
| Cash from Investing | 86.33% | 87.87% | 100.69% | 5.77% | -3,445.45% |
| Total Debt Issued | -69.68% | -82.55% | -48.95% | 564.50% | 131.48% |
| Total Debt Repaid | -40.46% | 33.85% | 26.56% | 77.23% | 71.38% |
| Issuance of Common Stock | -- | -- | -- | -- | -35.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -92.70% | -95.55% | -88.71% | -63.28% | 197.56% |
| Foreign Exchange rate Adjustments | 195.00% | -1,416.67% | -101.33% | -84.57% | -110.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -291.74% | 93.45% | 90.87% | 86.37% | -88.94% |